Table 2.
Distribution into severity categories of DAPSA score and patients reported outcomes.
| N° | 158 |
|---|---|
| DAPSA* | |
| Remission (%) | 10.8 |
| Low disease activity (%) | 23.4 |
| Moderate disease activity (%) | 36.1 |
| High disease activity (%) | 29.7 |
| Facit fatigue | |
| Score 0–20 (%) | 22,2 |
| Score 20–40 (%) | 46,8 |
| Score ≥ 40 (%) | 31,0 |
| PHQ-9 ¥ | |
| No depression (%) | 28 |
| Mild depression (%) | 32 |
| Moderate depression (%) | 18 |
| Moderate–severe depression (%) | 15 |
| Severe depression (%) | 7 |
| HAQ¶ | |
| Mild to moderate difficulty (%) | 51 |
| Moderate to severe disability (%) | 31 |
| Severe to very severe disability (%) | 18 |
| PSAID$ | |
| Patient-acceptable status (%) | 47.5 |
| Patient-non acceptable status (%) | 52.5 |
Patients reported outcomes in the enrolled sample. Data are presented as n (%). *DAPSA (Disease Activity in Psoriatic Arthritis); ¥PHQ-9 Patient Health Questionnaire-9; ¶HAQ Health Assessment Questionnaire; $PSAID Psoriatic Arthritis Impact of Disease; For categorization for DAPSA and PROMs, see the method section.